Development of CD33-Targeted Dual Drug-Loaded Nanoparticles for the Treatment of Pediatric Acute Myeloid Leukemia.

MLA

Carvalho, Ana M., et al. “Development of CD33-Targeted Dual Drug-Loaded Nanoparticles for the Treatment of Pediatric Acute Myeloid Leukemia.” Biomacromolecules, vol. 25, no. 10, Oct. 2024, pp. 6503–14. EBSCOhost, https://doi.org/10.1021/acs.biomac.4c00672.

APA

Carvalho, A. M., Greene, M. K., Smyth, P., Mutch, A., McLaughlin, K. M., Cairns, L. V., Mills, K. I., McCloskey, K. D., & Scott, C. J. (2024). Development of CD33-Targeted Dual Drug-Loaded Nanoparticles for the Treatment of Pediatric Acute Myeloid Leukemia. Biomacromolecules, 25(10), 6503–6514. https://doi.org/10.1021/acs.biomac.4c00672

Chicago

Carvalho, Ana M., Michelle K. Greene, Peter Smyth, Alexander Mutch, Kirsty M. McLaughlin, Lauren V. Cairns, Ken I. Mills, Karen D. McCloskey, and Christopher J. Scott. 2024. “Development of CD33-Targeted Dual Drug-Loaded Nanoparticles for the Treatment of Pediatric Acute Myeloid Leukemia.” Biomacromolecules 25 (10): 6503–14. doi:10.1021/acs.biomac.4c00672.